drugset / Trial / NCT04750902

A Clinical Trial to Assess the Safety and the Anti-caries Efficacy of COL 101 (Arginine) Non-fluoride Dentifrices in Comparison With 0.24% Sodium Fluoride (1100 Ppm F) Dentifrice Control in 10 to 14-year-old Children

NCT04750902

Phase 2 Completed 2000 enrolled Colgate Palmolive
RandomizedParallel-groupQuadruple-blindPrevention

Summary

The objective of this study is to assess the safety and to evaluate the anti-caries efficacy of COL101 (arginine) non-fluoride dentifrices compared to a 0.24% sodium fluoride dentifrice in 10-14 year-old children over a one year period.

Timeline

Start
2021-01-21
Primary completion
2024-02-29
Completion
2024-02-29

Drugs

EvaluationDrugModalityDoseRoute
Subject L-arginine Small molecule 1.5 % Topical
Subject L-arginine Small molecule 4 % Topical
Subject L-arginine Small molecule 8 % Topical
Comparator sodium fluoride Unknown 0.24 % Topical

Indications